Kiromic Biopharma, Inc. Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Kiromic Biopharma, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • Kiromic Biopharma, Inc. Return On Equity for the quarter ending September 30, 2024 was 326 %, a 13.7% decline year-over-year.
  • Kiromic Biopharma, Inc. annual Return On Equity for 2023 was 299 %.
  • Kiromic Biopharma, Inc. annual Return On Equity for 2022 was -528 %, a 303% decline from 2021.
  • Kiromic Biopharma, Inc. annual Return On Equity for 2021 was -131 %, a 69.4% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 299 +827 Jan 1, 2023 Dec 31, 2023
2022 -528 -397 -303% Jan 1, 2022 Dec 31, 2022
2021 -131 +296 +69.4% Jan 1, 2021 Dec 31, 2021
2020 -427 +184 +30.1% Jan 1, 2020 Dec 31, 2020
2019 -611 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.